142387-99-3 (雷诺嗪,Ranolazine)

结构式:
CAS号:
142387-99-3
中文名称:
雷诺嗪
英文名称:
Ranolazine
分子式:
C24H33N3O4
分子量:
427.536526441574

雷诺嗪(142387-99-3)名称与标识符

名称

中文别名:
雷诺嗪;(±)-N-(2, 6-二甲基苯基)-4-[2-羟基-3-(2-甲氧苯氧基)丙基]-1-哌嗪乙酰胺;盐酸索他洛尔-D7;
英文别名:
Ranolazine;n-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide;(±)-N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propry]-1-piperazine acetamide;(-)-Ranolazine;NSC-759100;(RS)-ranolazine;N-(2,6-Dimethylphenyl)-4-;(+-)-Ranolazine;Z68563450;RANOLAZINE [MART.];PB21724;110445-25-5;AB00698532-13;RANOLAZINE [MI];AKOS015889500;BD164322;RS 43285-003;NCGC00015897-02;RANOLAZINE [WHO-DD];Ranexa (TN);NCGC00015897-05;NCGC00095177-01;BCP04190;NSC 759100;MLS002154149;Tox21_110258_1;NCGC00095177-03;HMS1922F16;N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide;ranolazinum;HMS2230C19;(+-)-N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide;NCGC00015897-04;UNII-A6IEZ5M406;N-(2,6-Dimethyl-phenyl)-2-{4-[2-hydroxy-3-(2-methoxy-phenoxy)-propyl]-piperazin-1-yl}-acetamide;RANOLAZINE (MART.);Pharmakon1600-01505366;DB00243;NCGC00015897-22;(+/-)-Ranolazine;Latixa;KEG-1295;AB00698532_18;C01EB18;RS-43285-003;s1799;CHEBI:87681;Ranolazine [USAN];CCG-205139;NCGC00015897-08;HMS2093D21;ASPRUZYO;SB13209;rac-N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide;RANOLAZINE [USP-RS];RANOLAZINE [VANDF];N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}ethanimidic acid;XKLMZUWKNUAPSZ-UHFFFAOYSA-N;BDBM50173335;HMS3655M12;CAS-95635-55-5;HMS2098K06;AB00698532_16;BCP9000558;1080496-58-7;RANOLAZINE [ORANGE BOOK];A6IEZ5M406;Ranexa;HY-B0280;SMR000857382;D05700;racemic ranolazine;AC-1673;BCP0726000090;NCGC00015897-06;NSC782305;AMY14177;1-PIPERAZINEACETAMIDE, N-(2,6-DIMETHYLPHENYL)-4-(2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL)-, (+/-)-;SW197620-4;FT-0674327;BRD-A97674275-001-01-9;1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-, (+-)-;Ranolazine (USAN/INN);KS-1244;Q907104;GTPL7291;RAN D;HMS3884I10;HSDB 7924;NCGC00095177-02;SPECTRUM1505366;RANOLAZINE [INN];N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide;AB00698532-15;1-PIPERAZINEACETAMIDE, N-(2,6-DIMETHYLPHENYL)-4-(2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL)-, (+/-);ASPRUZYO SPRINKLE;1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-;SBI-0051032.P002;Ran4;EN300-122384;AB00698532_17;Ranolazine- Bio-X;SR-01000076216-5;Ranolazine (Ranexa);HMS3715K06;BSPBio_002276;142387-99-3;BRD-A97674275-001-04-3;(+/-)-N-(2,6-DIMETHYLPHENYL)-4-(2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL)-1-PIPERAZINEACETAMIDE;CHEMBL1404;95635-55-5;renolazine;N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxy-phenoxy)propyl)piperazin-1-yl)acetamide;CVT-303;DTXSID3045196;FT-0601594;(+/-)-4-(2-Hydroxy-3-(o-methoxyphenoxy)propyl)-1-piperazineaceto-2',6'-xylidide;SR-01000076216-8;AB00698532-11;AB00698532-14;CHEBI:87690;N-(2,6-DIMETHYLPHENYL)-2-(4-((2RS)-2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL)PIPERAZIN-1-YL)ACETAMIDE;MFCD00864690;SDCCGSBI-0051032.P003;NSC759100;Tox21_110258;SCHEMBL124665;HMS2090L09;HMS3369I08;NSC-782305;1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine;CVT 303;NS00002495;RANOLAZINE [EMA EPAR];DTXCID1025196;Ranolazine [USAN:INN:BAN];N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide;Lopac0_001062;N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)-propyl]piperazin-1-yl}-acetamide;Ranolazina;RS43285;SR-01000076216;NCGC00015897-03;rac-ranolazine;(+/-)-1-(3-(2-Methoxyphenoxy)-2-hydroxypropyl)-4-(n-(2,6-dimethylphenyl)carbamoylmethyl)piperazine;RANOLAZINE (USP-RS);

标识符

InChIKey:
XKLMZUWKNUAPSZ-UHFFFAOYSA-N
Inchi:
1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)
SMILES:
OC(COC1C=CC=CC=1OC)CN1CCN(CC(NC2C(C)=CC=CC=2C)=O)CC1

雷诺嗪(142387-99-3)物化性质

实验特性

  • LogP : 1.6

计算特性

  • 精确分子量 : 427.24710654g/mol
  • 氢键供体数量 : 2
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 9
  • 同位素质量 : 427.24710654g/mol
  • 重原子数量 : 31
  • 复杂度 : 531
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 1
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2.7
  • 拓扑分子极性表面积 : 74.3Ų